1. Home
  2. TXMD vs RGTIW Comparison

TXMD vs RGTIW Comparison

Compare TXMD & RGTIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXMD
  • RGTIW
  • Stock Information
  • Founded
  • TXMD 2008
  • RGTIW 2013
  • Country
  • TXMD United States
  • RGTIW United States
  • Employees
  • TXMD N/A
  • RGTIW 140
  • Industry
  • TXMD Biotechnology: Pharmaceutical Preparations
  • RGTIW Retail: Computer Software & Peripheral Equipment
  • Sector
  • TXMD Health Care
  • RGTIW Technology
  • Exchange
  • TXMD Nasdaq
  • RGTIW Nasdaq
  • Market Cap
  • TXMD 12.8M
  • RGTIW N/A
  • IPO Year
  • TXMD N/A
  • RGTIW N/A
  • Fundamental
  • Price
  • TXMD $1.18
  • RGTIW $4.78
  • Analyst Decision
  • TXMD
  • RGTIW
  • Analyst Count
  • TXMD 0
  • RGTIW 0
  • Target Price
  • TXMD N/A
  • RGTIW N/A
  • AVG Volume (30 Days)
  • TXMD 45.8K
  • RGTIW 850.8K
  • Earning Date
  • TXMD 08-11-2025
  • RGTIW 03-11-2025
  • Dividend Yield
  • TXMD N/A
  • RGTIW N/A
  • EPS Growth
  • TXMD N/A
  • RGTIW N/A
  • EPS
  • TXMD N/A
  • RGTIW N/A
  • Revenue
  • TXMD $1,841,000.00
  • RGTIW $11,892,000.00
  • Revenue This Year
  • TXMD $427.09
  • RGTIW N/A
  • Revenue Next Year
  • TXMD N/A
  • RGTIW N/A
  • P/E Ratio
  • TXMD N/A
  • RGTIW N/A
  • Revenue Growth
  • TXMD 53.55
  • RGTIW N/A
  • 52 Week Low
  • TXMD $0.70
  • RGTIW $4.28
  • 52 Week High
  • TXMD $2.44
  • RGTIW $4.75
  • Technical
  • Relative Strength Index (RSI)
  • TXMD 48.98
  • RGTIW N/A
  • Support Level
  • TXMD $0.98
  • RGTIW N/A
  • Resistance Level
  • TXMD $1.21
  • RGTIW N/A
  • Average True Range (ATR)
  • TXMD 0.09
  • RGTIW 0.00
  • MACD
  • TXMD 0.01
  • RGTIW 0.00
  • Stochastic Oscillator
  • TXMD 80.00
  • RGTIW 0.00

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About RGTIW Rigetti Computing Inc.

Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.

Share on Social Networks: